SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $679 | +20.4% | 33 | +175.0% | 0.00% | – |
| Q2 2023 | $564 | +11.9% | 12 | 0.0% | 0.00% | – |
| Q1 2023 | $504 | +10.0% | 12 | 0.0% | 0.00% | – |
| Q4 2022 | $458 | -99.8% | 12 | -99.4% | 0.00% | -100.0% |
| Q3 2019 | $294,000 | -23.4% | 2,100 | 0.0% | 0.02% | -25.8% |
| Q2 2019 | $384,000 | -19.5% | 2,100 | -30.0% | 0.03% | -20.5% |
| Q1 2019 | $477,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |